COMPANY

Velorum Therapeutics

HQ: South San Francisco, CA source · velorumtx.com ↗ · West Coast

Keywords: oncology renal

Location: South San Francisco, CA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $1.26M (SBIR Phase II 5R44CA291444-02, continuation, notice Aug 6, 2026). NIH RePORTER 5R44CA291444-02 (Aug 6, 2026)
Evidence (1 event)
- Aug 6, 2026 · NIH RePORTER 5R44CA291444-02
  Organization: VELORUM THERAPEUTICS INC.; City/State: PLANO, TX; Project number: 5R44CA291444-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-08-06; FY total cost (award amount): 1258345; Administering IC: National Cancer Institute; Project title: VEL-03: IND-enabling development of a novel therapeutic approach for treatment of non-small cell lung cancer and other solid tumors; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals